Title : Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy.

Pub. Date : 2015 Nov

PMID : 26398317






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Treatment with anti-CD20-hIFNalpha sensitized the cells to apoptosis by CDDP, doxorubicin and Treanda. cddp interferon alpha 1 Homo sapiens
2 Treatment with SB203580 enhanced the sensitization of the resistant clone by anti-CD20-hIFNalpha to CDDP apoptosis. cddp interferon alpha 1 Homo sapiens